Condition
Smoke Exposure
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06841913Phase 4RecruitingPrimary
Woodsmoke Exposure, Influenza Infection, and Nasal Immunity
NCT07364890Not ApplicableNot Yet RecruitingPrimary
Platelet-Derived Growth Factors to Enhance Healing and Reduce Post-Extraction Complications in Smokers
NCT06723470Not Yet RecruitingPrimary
Effect of Passive Smoking on Functional Capacity, Cognition and Academic Performance in Primary School Children
NCT01592682Not ApplicableCompleted
Creating Smokefree Living Together for Chinese Household Pairs
Showing all 4 trials